Chris Sharpe

Chris Sharpe has extensive experience in regulatory affairs, having held various roles in different companies over the years. Chris is currently serving as the VP of Regulatory Affairs at Quell Therapeutics since December 2021. Prior to this, they worked as the Head of Regulatory Affairs at the same company from September 2019 to December 2021.

Before joining Quell Therapeutics, Chris worked at Biogen as the Global Regulatory Lead from July 2018 to September 2019. Chris also served as the Associate Director of Regulatory Affairs for UK and Ireland at Biogen from July 2015 to July 2018.

Prior to Biogen, Chris worked as the Director of Regulatory Affairs (EU) at Cell Medica Ltd. from December 2012 to July 2015. Chris also gained experience at Allergan as the EU Regulatory Affairs Senior Manager from January 2012 to December 2012, and as the Regulatory Affairs Manager from November 2010 to December 2011.

Chris began their career at MHRA, where they worked as a Pharmaceutical Assessor from February 2009 to November 2010. Chris also gained experience at Wyeth Pharmaceuticals as a Regulatory Affairs Officer from June 2008 to January 2009, and at GlaxoSmithKline as a Regulatory Executive from September 2006 to June 2008.

Chris started their professional journey at Lloyds Pharmacy, where they worked as a Locum Pharmacist from August 2005 to September 2006.

Chris Sharpe obtained a Master's degree in Pharmacy from the University of Nottingham, studying from 2000 to 2004.